Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800).
about
Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Atrasentan in Patients With Ad ...... Cancer Research Group (E6800).
@ast
Atrasentan in Patients With Ad ...... Cancer Research Group (E6800).
@en
type
label
Atrasentan in Patients With Ad ...... Cancer Research Group (E6800).
@ast
Atrasentan in Patients With Ad ...... Cancer Research Group (E6800).
@en
prefLabel
Atrasentan in Patients With Ad ...... Cancer Research Group (E6800).
@ast
Atrasentan in Patients With Ad ...... Cancer Research Group (E6800).
@en
P2093
P2860
P1476
Atrasentan in Patients With Ad ...... Cancer Research Group (E6800).
@en
P2093
Janice P Dutcher
Judith Manola
Michael A Carducci
Steven Rousey
Suresh G Nair
P2860
P304
531-539.e1
P356
10.1016/J.CLGC.2015.07.002
P407
P577
2015-07-17T00:00:00Z